chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a consumer refers to an approximately 77 years old male patient with cancer. Approximately in May 2010, reported as approximately 3 years ago, patient was vaccinated with a dose of ZOSTAVAX (dose, route and lot number and expiration date not reported). Reporter stated that patient wasn't on anything and was pretty healthy. No concomitant medications were reported. On an unknown date the patient experienced cancer. Approximately in May 2011, reported as about two years ago, patient died. Reporter stated that she didn't know if it was from cancer or vaccine and none of doctors could pinpoint the reason of death. On an unknown date the patient even had to have open heart surgery. Consumer reported also that at the end of his life (approximately in 2011) he experienced breaking out over his entire body, extremely painful, he couldn't eat, couldn't sleep and had temporary loss of bowel control. The patient complained also about pain through his entire body and severe fatigue. On an unknown date patient was hospitalized and then moved to hospice facility. He sought medical attention. The treatment given for the events were reported by the consumer as: the doctors said "maybe it's this maybe it's that". The outcome of open heart surgery, cancer, breaking out over his entire body, extremely painful, couldn't eat, couldn't sleep, temporary loss of bowel control, pain through his entire body and severe fatigue was not reported. The relatedness open heart surgery, cancer, breaking out over his entire body, extremely painful, couldn't eat, couldn't sleep, temporary loss of bowel control, pain through his entire body and severe fatigue between and ZOSTAVAX was not reported. Additional information is not expected.
Patient presented to the ED and was subsequently hospitalized for cardiomyopathy secondary to a drug, obstructing colon mass, laparoscopic right hemicolectomy with diverting loop ileostomy within 6 weeks of receiving covid vaccination.
4pm, 1 hour after shot, throad swelling, stuffy headache, heart bm 99 to 87 to 96, started itching on left arm near wrist, arm where shit was. etc., For next 3 hours.  Took antihistamine chlortrimitron 2, mucinex 1, drank water.   6pm, hbm 87, 78, felt like palpations, throat more swollen.  Kept clearing throat to keep open.   9pm, bm 82, 78, 93, throat not worse, drank water.  With heart rate so high, I didn't take epipen.   9:10pm went to bed  12am woke up throwing up intensely.  Took prescription promethazine let dissolve in mouth, went to bed.   9am woke up with little nausea, light headache, swollen raw throat.  4:30pm, 25+ hours after shot, throat still really swollen, arm sore, tired.
Patient returned from deployment in August 2003, was in healthy state, was lifting weights, running, weighed 230 pounds. His post-deployment health assessment indicated that he was in good health, with no current symptoms of PTSD at that time. He apparently had experienced some numbness and tingling in his hands or feet, and skin diseases or rashes that had resolved. He had at the time of his return already received SPV and his first three in series of AVA. His fourth AVA was given 29 September, 2003 in a site near his previous SPV site.  That night he began getting cold sweats. For the next four months he had daily recurrences of a "little bump" appearing at his AVA site on his upper R arm. He describes the lesion as being pink like a mosquito bite with no fluid in the bump, and not blister-like. The bump would come up visibly and be itchy while up, and then would go away. After the four months of daily occurrences the frequency decreased to occasional, and has not appeared again since September of 2004. During the same period he found himself getting cold sweats at night, and anxiety attacks would strike suddenly. He became "nagged" about little things as well as impatient, wanting things done now, instead of being able to be patient. He had increased teeth clenching for 1-1 ½ months. As of July 2004 he no longer experiences the anxiety or teeth clenching.
Mother describes hearing baby having breathing problems. She found baby was vomiting profusely & choking. Then noticed baby had red hives on face & chest; abdomen. By the time infant returned to office at 12:55 symptoms not present. Temp 97.3.
Patient developed a rash on left arm and neck within 24 hours after receiving vaccine. The rash resolved itself within a few days.
Initially pt felt dizzy, faint, pt moved to floor from chair. Called 911 after pt stated lip tingling. Then face began tingling. Asked pt if he'd experienced tingling w/ his aversion to needles in past and he stated no. Had experienced dizziness, feeling faint in past bus said this was different.  When pt stated that "throat felt funny", recommended he may need dose of epipen, he agreed and consented to epipen. Adminstered epipen. Called 911 again at 5 minute mark, EMS arrived shortly thereafter and took to ER for observation. After evaluation, ER believes pt suffered severe panic attack that make him feel like throat was being affected.
bloating; burping; a little diarrhea; Ethylene Glycol is an ingredient and it is Miralax.; This is a spontaneous report from a contactable physician. 2 female patients, both are about 50 years old. This case is for the first female patient out of two. A 50-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration was not reported) via unspecified route of administration on 25Apr2021 as 2nd dose, single dose for COVID-19 immunization. Medical history and concomitant medication were not reported. Previously patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration was not reported) via unspecified route of administration as 1st dose, single dose for COVID-19 immunization. It was reported that both patient received their 2nd Pfizer vaccine dose on 25Apr2021. Since their 2nd dose both have been experiencing bloating, burping and a little diarrhea for over a month now. They have no pain, and their abdominal ultrasound was normal. HCP stated if that continued, will do a CT scan in a couple weeks, but really thought it was related to the vaccine. Ethylene Glycol was an ingredient, and it was Miralax. So, all made sense. The lab test and procedure which included abdominal ultrasound was normal on unspecified date. The outcome of the events was not recovered and outcome of the event reaction to excipient was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021607602 same reporter/drug/AE with different patient
Pfizer COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 7/30/2021 and 8/20/2021.Patient initially presented to the Hospital, on 12/28/2021 due to syncopal episode at home.  Reported nausea and fatigue prior to syncopal episode, denied chest pain, dizziness, fever/chills or shortness of breath.  Upon further evaluation at the outside hospital patient was noted to have white blood cell count of 50000, anemia with hemoglobin of 6.8, and thrombocytopenia with platelet count of 6000. CT scan of chest identified a large pericardial effusion with possible tamponade, and taken for pericardiocentesis w/pericardial window by CT surgery.  Developed significant hypoxemia postoperatively and COVID test revealed positive PCR.  Continued to develop worsening hypoxemia and requested transfer to the Medical Center (MC) for HLOC. Arrived to MC on high-flow nasal cannula at 10 liters/minute, awake, alert and oriented x3 in no acute distress with O2 saturations greater than 92%. On 1/3/2022 became hypoxic requiring AirVo, on 1/18/2022  ECHO with intact LVEF with moderate pericardial effusion without tamponade, on 1/19/2022 transferred to ICU for acute respiratory distress, experienced sudden cardiac arrest and PEA with return of spontaneous circulation after approximately 15 minutes which required intubation. On 1/20/2022 experienced bradycardia and desaturations on ventilator and second cardiac arrest. Formal TTE and POC US during code event both showed effusion without evidence of tamponade physiology. Arrest thought to be hypoxemic. ROSC achieved briefly x4 with ACLS, non-sustained, eventual TOD 1031.
Severe Chills. Temperature of 101. Severe body aches. Severe headache.
Presented 2 days, post vax, with fever, diarrhea and swelling to injection site.
On 10-17-07 noted edema, redness, warm to touch, and painful in left upper ext.  On 10-18-07 pt. assessed by Dr. (temp. 97.6, noted 6.5 X 3.0 cm induration and redness).  Applied ice and Naprosyn ordered.  Spoke with pt. on 10-19-07; s/s: edema, redness, pain, and warm to touch has decreased. No further s/s noted.
BLURRED VISION; CHEST PAIN/ FELT LIKE A TRUCK SITTING ON STERNUM; JOINT PAIN; CHILLS; MUSCLE PAIN; TEMPERATURE 99.7; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 09-NOV-2021 15:30 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 09-NOV-2021, the patient experienced chest pain/ felt like a truck sitting on sternum. On 09-NOV-2021, the patient experienced joint pain. On 09-NOV-2021, the patient experienced chills. On 09-NOV-2021, the patient experienced muscle pain. On 09-NOV-2021, the patient experienced temperature 99.7. Laboratory data included: Body temperature (NR: not provided) 99.7 F. On 10-NOV-2021, the patient experienced blurred vision. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from temperature 99.7, chills, chest pain/ felt like a truck sitting on sternum, blurred vision, muscle pain, and joint pain. This report was non-serious.
About one week after the vaccine I noticed my whole body feeling very inflamed. My joints were all achy and I began getting very sore after my work outs. Two-three weeks after I noticed that my left breast had swollen and was larger than usual, I know that can be a side effect and assumed it would pass. Over the following weeks I continued to monitor my over all inflammation and left breast and I have noticed my left nipple is now also getting larger. It is very sensitive and tender to the touch.
Expired Hiberix administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 2-month-old male patient who received Hib (Hiberix) (batch number cH392, expiry date 22-MAR-2023) for prophylaxis.   On 03-MAY-2023, the patient received Hiberix. On 03-MAY-2023, an unknown time after receiving Hiberix, the patient experienced expired vaccine used (Verbatim: Expired Hiberix administered). The outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 03-MAY-2023 The medical assistant reported that two patients (twins) were administered an expired dose of Hiberix. The reporter declined to follow up. The patient received an expired dose of Havirx, which led to expired vaccine used. This case was linked with case US2023064471, reported by same reporter for different patient.; Sender's Comments:  US-GSK-US2023064471:Same reporter (female patient)
Patient developed an acute allergic reaction with urticaria, respiratory distress, upper airway edema, hypotension.  Patient was treated with 0.3mg IM epinephrine, 50mg IV diphenhydramine, 125 mg Solu-Medrol and 1 L of IV normal saline.  Patient improved after these interventions and was observed for 3 hours in the emergency department.  Due to reaction with #1 Moderna on 28JAN2021 041L20A member opted to receive the 1 dose of J&J with providers approval.
I was weak all over/I didn't want to get out of bed; Malaise; Headache; This case was received via United Kingdom MHRA (Reference number: MOD21-131145) on 16-Aug-2021 and was forwarded to Moderna on 16-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (I was weak all over/I didn't want to get out of bed), MALAISE (Malaise) and HEADACHE (Headache) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 013L20A) for COVID-19 vaccination.     The patient's past medical history included Arm discomfort (a metal rod in the left humorous), Knee replacement (Both knees replaced) and Hip replacement (Left hip replacement). Concurrent medical conditions included Arthritis (Severe arthritis), Scoliosis and Stenosis.   On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced ASTHENIA (I was weak all over/I didn't want to get out of bed), MALAISE (Malaise) and HEADACHE (Headache). At the time of the report, ASTHENIA (I was weak all over/I didn't want to get out of bed), MALAISE (Malaise) and HEADACHE (Headache) had resolved.            No concomitant medication was reported by reporter. No treatment medication was reported by reporter.  The events lasted for 4 to 5 hours, came and went away for the patient.   Reporter did not allow further contact
Initial report was received on 08 April 2013 from an electronic lay press article. A 10-year-old female patient had received an injection of INFLUENZA VACCINE (trade name, manufacturer, lot number, route, site and exact date of administration not reported) in December 2012. The patient was diagnosed with strain B flu on 20 March 2013. Three days after the patient was diagnosed with the flu, she was rushed to the hospital after complaining of stomach and chest pains and difficulty breathing. She went into cardiac arrest the following morning, and doctors revived her after performing CPR for about two hours. She was placed on a life support system to restore oxygen to her blood. Doctors also put her on a machine to do the work of her heart while waiting for a transplant. The infection morphed into a serious case of myocarditis. The patient died from flu complications at 10:45 AM on 05 April 2013. Outcome was fatal. Documents held by sender: none.
I31.9 - Disease of pericardium, unspecified I31.9 - Pericarditis
After receiving the second dose Pfizer Covid Vaccine, the caller lost sense of smell for a day; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date Jan2021 (Batch/Lot number: unknown) as dose 2, single for COVID -19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: CELEBREX (ongoing). Vaccination history included: Bnt162b2 (Dose 1, Single), administration date: Dec2020, for COVID -19 immunization.  The following information was reported: ANOSMIA (non-serious) with onset 2021, outcome "recovered" (2021), described as "After receiving the second dose Pfizer COVID Vaccine, the caller lost sense of smell for a day".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Additional Information: The patient's doctor told not to take the Pfizer Covid Vaccine. The doctor did not recommend the booster dose Pfizer Covid Vaccine. 25 years ago the patient took Celebrex and was on Celebrex and after calling Pfizer, Pfizer use to send Celebrex when the caller used to be in and that was okay. But now the patient has everything. The patient needed to get the Pfizer Covid Vaccine, so received the Pfizer Covid Vaccine.
Employee experienced shortness of breath, chest tightness, nausea and headache after vaccination and needed prolonged monitoring post vaccination. Improved with rest.
Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium
Possible effect of the vaccine   Shingles   I have Hx of chickenpox  when I was young  30 years ago. A dormant Virus could have been reactivated .  I have no recollection of exposure to someone with  shingles  in the past few months .
Information has been received from a medical assistant and medical record concerning a 14 year old former healthy female with no known allergies who on 08-OCT-2008 was vaccinated intramuscularly with a third dose of GARDASIL (lot number 659964/1978U) in the left deltoid, a second dose of VARIVAX (Merck) (lot number 661661/0995X) subcutaneously in the right arm and a second dose of HAVRIX (lot number AHA0B747AA) intramuscularly in the right deltoid. On 02-FEB-2009 at 07:47 in the morning the patient experienced syncope and was transferred to the hospital emergency room. The head CT was negative and blood sugar was 97 which was normal. The patient was diagnosed with possible electrical shock. It was reported that the patient stated that she was shocked via hair straightener. The patient saw the physician on the same day and was diagnosed with possible seizure post electrical shock. On 10-APR-2009 the patient experienced seizure for 2 minutes, fell and hit her head on the floor and was sent to ER. The patient was started with TEGRETOL 200 mg twice a day. On 25-MAY-2009 dose of TEGRETOL was increased to 400 mg twice a day then 500 mg twice a day. The patient was also treated with folic acid 5 mg daily. On 04-MAY-2009 the patient experienced seizure for the third time. On 25-MAY-2009 therapy with TEGRETOL was discontinued and changed to KEPPRA. It was reported that the patient recovered on medications on 23-SEP-2009. On 29-SEP-2009 electroencephalograpy (EEG) showed abnormal for 3 electrographic seizures. Seizures were considered to be an other important medical event by the reporter. Additional information is not expected. All available medical records will be provided upon request.  01/05/10 MR received for DOS 09/17/09. DX: Grand mal seizures.  Pt presented with grand mal sz lasting 5 mins and loud screem. Pt A, Ox3, comfortable; neuro exam: normal. Pt discharged home in stable condition.
MD called into room within a few minutes after vaccines given. Child had developed 2 urticarial lesions. Wheal and flare. One on each thigh. Urticaria corresponded to Varicella on (L) thigh and MMR on (R) thigh. Child also had flushing on cheeks. No breathing difficulty. Lungs clear. 10mg BENADRYL given. Reaction resolved.
Exteme swelling of Right Arm- I saw the arm about 36 hours after injection and at that time it was over the entire outer arm (60 % of circumference) and the whole outer arm 5-6 inches. Very warm and tender, ROM of arm was good and elbow and  hand normal  Rx with cold and tylenol adn 24 hrs later was almost normal
10/02/2005 red spot in am, got worse by the evening, slight fever Tylenol brings temp back to normal. DX Rubeola per FNPC, Treatment Tylenol use, Calamine, Baking soda baths, Aveeno Bath.
I broke out in hives and a very itchy rash all over my body the day after receiving the Moderna vaccine. It had been a week and the rash was continuing to grow so I went to a med express clinic to be seen today. They prescribed me with Prednisone and ruled it as "contact dermatitis". I have a history with eczema and I'm wondering if the vaccine caused a massive flare up or if it was just coincidence.  The prednisone already seems to be helping.  This was the only adverse event after getting my vaccine.
Pt had right thalamus infarct 15-30 minutes after receiving vaccination. Paresthesia to right arm and right side of face.
joint pain; stomach cramps; tremors; 100.4 Fever; sore arm; pain in muscle; Severe diarrhea; Nausea; This is a spontaneous report from a contactable Consumer. This 73-Year-old male Consumer (patient) reported that: A 73-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot Number were not reported), via unspecified route administration on an unspecified date (at the age of 73-years-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient had medical history included heart disease, multiple strokes and known allergies: penicillin all from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient had not received other vaccine within four weeks, Prior to vaccination. The patient did not receive other medications in two weeks prior vaccination. The patient hat not covid prior vaccination. Patient had not covid tested post vaccination. On an unspecified date after the first dose of vaccination, the patient experienced joint pain, stomach cramps, tremors, 100.4 fever, sore arm, pain in muscle, severe diarrhea and nausea. It was reported that first three days a sore arm only. Woke at 03:00 day four with fever of 100.4, tremors, nausea pain in muscles and joints. Severe diarrhea. This lasted for approximate 4 hours. The only symptom remaining was joint pain and stomach cramps. The patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198), via unspecified route administration, administered in left arm on 22Feb2021 15:00 (at the age of 73-years-old) as DOSE 2, SINGLE for COVID-19 immunization. On an unspecified date, the patient underwent lab tests and procedures which included body temperature: 100.4 (day four with fever of 100.4.) The patient did not receive any treatment for the adverse events. The outcome of event severe diarrhea was recovered on an unspecified date and joints pain and stomach cramps was not recovered, while outcome of other events was reported as unknown.  No follow-up attempts are possible. No further information is expected.
This is a spontaneous report from a contactable female consumer reporting for herself. This female patient of unknown age and race/ethnicity received on an unspecified date PREVNAR 13 at 0.5 ml single dose for immunization. Concomitant medications and medical history were not reported. On an unspecified date, the patient had a bronchial infection. Outcome was not reported.
Fully vaccinated on 3/3/2021 Tested COVID-19 positive on 1/23/2022 with respiratory symptoms decreasing in oxygen saturation requiring oxygen to be administered. History Kidney transplant 2004, end stage renal disease with L AV fistula, osteomyelitis, atrial fibrillation
Woke up with bell's palsy July 4, 2021, took 2 baby aspirin and went immediately to Emergency Department at  to receive evaluation and treatment.  Condition has not improved as of this date, September 24, 2021.  I still have complete paralysis of the left side of my face.